Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Chief Medical Officer

Dr Richard Stefanacci has focused his career on improving health outcomes, especially for some of the most vulnerable populations. This has been achieved through several avenues, beginning with his continued active role as a treating internist/geriatrician. He has also put this focus into practice as chief medical officer for several management care plans, including ElderHealth/Bravo/HealthSpring/Cigna and PACE (Program for All-inclusive Care for the Elderly) programs, as well as in his current role as P&T Committee member for several national plans.

On the policy side, Dr. Stefanacci served as Health Policy Scholar for the Centers for Medicare & Medicaid Services through his role at Thomas Jefferson University, College of Population Health where he maintains a faculty appointment. He has more than 500 publications and has delivered well over 1000 lectures, both nationally and internationally, focused on improving health outcomes. Today, Dr. Stefanacci is actively engaged in leading population health activities for numerous health systems and payer groups.

His recognized expertise has led to Dr Stefanacci being appointed to serve on the American Society of Consultant Pharmacists (ASCP) and the American Medical Directors Association Foundation Boards, as well as being honored as an honorary lifetime member of ASCP and the National Association of Directors of Nursing. Dr Stefanacci has achieved recognition as a fellow in both the College of Physicians of Philadelphia and American Geriatric Society, and was recently awarded the Humanism in Aging Leadership Award from the University of New England.

Finally, Dr Stefanacci’s work for vulnerable populations is very personal, stemming from his involvement with the Go4theGoal Foundation (www.Go4theGoal.org), a 501(c)(3) public charity that he founded with his family and friends when his oldest son, Richard, was diagnosed with Ewing’s sarcoma. Since its inception, the foundation has raised several million dollars to assist hundreds of children affected by cancer at nearly 100 children’s hospitals across the country, while also funding cutting-edge research to find a cure. This research work is directed by the foundation’s panel of experts, which includes several current and past federal government leaders in rare diseases. As you can see, whether as a practicing physician, policy expert, or patient advocate, Dr Stefanacci’s life’s work has focused on improving care outcomes for some of the most at-risk individuals.